Live tape
Top 8, mentions 7d19,874GOOGL8,320 mentions▲ +0.02MSFT2,075 mentions▲ +0.04AMZN1,920 mentions▲ +0.04INTC1,851 mentions▲ +0.03META1,493 mentions▲ +0.03NVDA1,473 mentions▲ +0.06RDDT1,433 mentions▲ +0.04TSLA1,309 mentions▲ +0.05

Equity · Healthcare

AVXL

NASDAQ

Anavex Life Sciences (AVXL)

1.18 USD −9.58% vs prior close Oct 30, 2026
Anavex Life Sciences Corp. price graph
64 sessions
4 1 3 Aug 30 Oct

The line runs 2.96 USD on 3 August through 1.18 USD on 30 October, on a scale from 1 to 4. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView
Market cap
109.4M USD
EPS, diluted, year to Sep 2025
−0.54 USD
Avg volume
89.9K

as of Oct 30, 2026

Have Anavex Life Sciences (AVXL) insiders bought or sold shares recently?

AVXL has no Form 4 filing in the last 90 days, so there is no summary for that window. The most recent filings we hold are below, the newest dated 2 October 2025.

Form 4

Have Anavex Life Sciences (AVXL) insiders bought or sold shares recently?
ReportedInsiderTypeSharesValue
02 Oct 2025MISSLING CHRISTOPHER UPresident and CEOAward125,000
02 Oct 2025Boenisch SandraPFO & TreasurerAward12,500

Which funds hold Anavex Life Sciences (AVXL)?

8 of the 45 institutional funds we track reported a Anavex Life Sciences position for the quarter ended 30 Jun 2026 — a combined 14.5M USD; the latest of those filings landed 02 Sep 2026.

Form 13F

Which funds hold Anavex Life Sciences (AVXL)?
FundPositionSharesValueShares q/q
Two Sigma InvestmentsHeld (±25%)3,046,5387.9M USD−6.2%
AQR Capital ManagementAdded963,0142.5M USD+27.2%
Marshall WaceAdded889,5232.3M USD+112.0%
Citadel AdvisorsTrimmed329,115852K USD−41.2%
Point72 Asset ManagementNew position157,486408K USD
D. E. Shaw & Co.Added115,462299K USD+157.4%
Millennium ManagementNew position60,483157K USD
Tudor Investment CorpTrimmed20,37753K USD−52.3%
Renaissance TechnologiesExited

Have members of Congress traded Anavex Life Sciences (AVXL)?

The most recent congressional trade disclosed in Anavex Life Sciences is a sale by Sara Jacobs (house, CA), dated 12 Dec 2022.

STOCK Act disclosures

Have members of Congress traded Anavex Life Sciences (AVXL)?
TradedMemberTypeAmountFiled after
12 Dec 2022Sara Jacobshouse · Democrat–CASale1K USD–15K USD39 days
12 Oct 2022Sara Jacobshouse · Democrat–CAPurchase1K USD–15K USD35 days

What has been filed or recorded for Anavex Life Sciences (AVXL)?

The filings we hold for Anavex Life Sciences, newest first: 9 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 4 reported financial figures, the latest dated 14 Oct 2026. No next earnings date is announced in SEC filings yet.

What has been filed or recorded for Anavex Life Sciences (AVXL)?
And
14 Oct 2026Fails to deliverShares failed to deliver1 shares1 USD notional · <0.001% of shares out
13 Oct 2026Fails to deliverShares failed to deliver20,138 shares30K USD notional · 0.022% of shares out
09 Oct 2026Fails to deliverShares failed to deliver21,139 shares33K USD notional · 0.023% of shares out
08 Oct 2026Fails to deliverShares failed to deliver3,356 shares5K USD notional · 0.004% of shares out
02 Oct 2026Fails to deliverShares failed to deliver12,340 shares23K USD notional · 0.013% of shares out
24 Sep 2026Fails to deliverShares failed to deliver29,909 shares70K USD notional · 0.032% of shares out
23 Sep 2026Fails to deliverShares failed to deliver1,844 shares5K USD notional · 0.002% of shares out
22 Sep 2026Fails to deliverShares failed to deliver38,689 shares93K USD notional · 0.042% of shares out
21 Sep 2026Fails to deliverShares failed to deliver69 shares167 USD notional · <0.001% of shares out
30 Jun 2026Quarterly earningsQ3 2026 reportedEPS 0.08 USD
30 Jun 2026FinancialsTotal assets120.1M USDat period end
30 Jun 2026FinancialsTotal equity112.4M USDat period end
31 Mar 2026Quarterly earningsQ2 2026 reportedEPS −0.06 USD
31 Dec 2025Quarterly earningsQ1 2026 reportedEPS −0.06 USD
30 Sep 2025Annual reportFY 2025 reportedEPS −0.54 USD
30 Sep 2025FinancialsNet income−46.4M USDfiscal year
30 Sep 2025FinancialsDiluted EPS−0.54 USDfiscal year
30 Jun 2025Quarterly earningsQ3 2025 reportedEPS −0.16 USD
31 Mar 2025Quarterly earningsQ2 2025 reportedEPS −0.13 USD
31 Dec 2024Quarterly earningsQ1 2025 reportedEPS −0.14 USD
30 Sep 2024Annual reportFY 2024 reportedEPS −0.52 USD

Anavex Life Sciences (AVXL): frequently asked questions

From live data
1.18

What did Anavex Life Sciences shares close at?

Anavex Life Sciences closed at 1.18 USD on 30 Oct 2026, down 9.58% on the close before. That is the end-of-day price from Finazon, not a live quote.

109.4M

What is Anavex Life Sciences’ market cap?

Anavex Life Sciences is worth 109.4M USD by market value as of 30 Oct 2026, which is the share price times the shares on issue from its SEC filings.

Have Anavex Life Sciences insiders bought or sold shares recently?

No Anavex Life Sciences insider has filed a Form 4 in the last 90 days; the most recent filing we hold is dated 2 Oct 2025 (SEC Form 4). See Insiders

8 of 45

Which funds own Anavex Life Sciences?

8 of the 45 funds we track reported a Anavex Life Sciences position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were Two Sigma Investments, AQR Capital Management and Marshall Wace. See Funds

2 trades

Have members of Congress traded Anavex Life Sciences?

Yes. 2 trades in Anavex Life Sciences appear in the congressional disclosures we hold; the latest is a sale by Sara Jacobs (House, CA) dated 12 Dec 2022, filed 20 Jan 2023. Amounts are disclosed as ranges, and a filing can follow the trade by up to 45 days. See Congress

0.08

When did Anavex Life Sciences last report earnings?

Anavex Life Sciences last reported earnings on 30 Jun 2026 for Q3 2026, with EPS of 0.08 USD; no next date is announced in SEC filings yet. See Filings

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

References
  1. Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARForm 4 filings (insider transactions)
  4. SEC EDGAR13F filings
  5. House disclosuresU.S. House of Representatives financial disclosures
  6. SECSEC fails-to-deliver (CNS) data
  7. SEC EDGARXBRL company facts, latest period ended 30 Jun 2026
  8. SEC EDGARreported earnings figures and scheduled report dates
  9. SEC EDGARValuation computed from SEC EDGAR filings